AngioDynamics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
AngioDynamics, Inc. income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec 2025May 2024May 2023May 2022May 2021May 2020May 2019
Revenue & Gross Profit
Revenue292.50303.91338.75316.22291.01264.16270.63
Cost of Revenue134.79149.22164.51150.49134.22113.89114.63
Gross Profit157.71154.70174.25165.73156.79150.27156.00
Operating Expenses
Research & Development26.2231.3229.6930.4836.3929.6828.26
Selling, General & Administrative145.23144.18144.45134.01117.22116.51111.73
Operating Expenses197.66188.54192.93183.95171.75317.37157.05
Operating Income-39.95-33.84-18.68-18.22-14.96-167.10-1.05
Other Income/Expense
Interest Income0.981.610.000.000.000.000.00
Interest Expense0.000.00-2.70-0.69-0.860.005.10
Other Income/Expense5.92-0.82-0.55-0.790.090.13-8.56
Income
Income Before Tax-34.03-191.64-54.44-29.95-36.05-168.14-14.70
Income Tax Expense-0.04-7.29-2.00-3.40-4.50-1.35-3.56
Net Income-33.99-184.35-52.44-26.55-31.55-166.7961.34
Net Income - Continuous Operations-33.99-184.35-52.44-26.550.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.00
EBITDA1.74-8.5312.1911.1310.95-143.4216.28
EBIT-24.06-33.84-18.68-18.22-14.96-167.23-9.60
Depreciation & Amortization25.8025.3130.8729.3525.9218.1017.06
Earnings Per Share
Basic EPS-1.00-5.00-1.00-1.00-1.00-4.002.00
Diluted EPS-1.00-5.00-1.00-1.00-1.00-4.002.00
Basic Shares Outstanding40.9840.1839.4839.0138.3437.9637.49
Diluted Shares Outstanding40.9840.1839.4839.0138.3437.9637.49